The Global Blepharoplasty Market will Hit $5.7 Billion by 2028, at a CAGR of 8%

Blepharoplasty Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Blepharoplasty Market size is expected to reach $5.7 billion by 2028, rising at a market growth of 8.0% CAGR during the forecast period.

The Lower Eyelid segment is showcasing a CAGR of 8.4% during (2022 - 2028). The growing elderly population and the need for less invasive surgical techniques are to blame. Surgery on the lower eyelids removes fat, saggy skin, and excess skin. Moreover, it eliminates eyelid wrinkles, dark circles, and bags beneath the eyes. These are a few of the primary reasons that, throughout the study period, drive both the market for blepharoplasty and the demand for eye surgical treatments.

The Female segment acquired maximum revenue share in the Global Blepharoplasty Market by Gender in 2021 thereby, achieving a market value of $4.4 billion by 2028. This is related to a growing desire to enhance appearance via eye rejuvenation, which makes the eyes seem more young and rejuvenated.

The Clinics segment has shown the growth rate of 8.1% during (2022 - 2028). This is linked to the availability of cutting-edge technology and skilled medical personnel. Patients generally choose outpatient treatments that may be done in dermatological clinics over hospital procedures that might need anesthesia. Outpatient procedures are less intrusive. The fastest-growing market globally is capitalized on by less invasive laser blepharoplasty procedures.

The North America market dominated the Global Blepharoplasty Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2.2 billion by 2028. The Europe market is exhibiting a CAGR of 7.3% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 9% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/blepharoplasty-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Sisram Medical Ltd (Fosun Pharma), AbbVie, Inc., LightScalpel, Inc, Surgical Holdings, GRAND AESPIO, INC., London Bridge Plastic Surgery, Medline Industries, Inc., and Lumenis Be Ltd.

Global Blepharoplasty Market Segmentation

By Type

• Upper Eyelid
• Lower Eyelid
• Combination Eyelid Surgery

By Gender

• Female
• Male

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centre

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Medtronic PLC
• Sisram Medical Ltd (Fosun Pharma)
• AbbVie, Inc.
• LightScalpel, Inc
• Surgical Holdings
• GRAND AESPIO, INC.
• London Bridge Plastic Surgery
• Medline Industries, Inc.
• Lumenis Be Ltd.

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

North America Blepharoplasty Market size & Opportunities 2022-2028

Europe Blepharoplasty Market & Growth Forecast 2022-2028

Asia Pacific Blepharoplasty Market Share & Industry Outlook to 2028

LAMEA Blepharoplasty Market Growth, Trends & Forecasts 2022-2028